Dominic Seitz

Dominic is a Partner in Simon-Kucher’s Life Sciences division in Frankfurt. He helps develop and drive strategic launch and lifecycle product and portfolio strategies for global pharmaceutical and biotechnology companies

Adrien Debacq

Dave Clement

Dave is a Partner and Head of Simon-Kucher’s New York office, where he supports top-line growth strategy design and implementation for clients in a variety of industries. Dave’s areas of expertise include customer segmentation, price setting and implementation, product and service design, and rewards and loyalty programs.

Jan Haemer

Jan Haemer is a Partner in Simon-Kucher's global Chemicals & Construction practice in Frankfurt. His focus is product portfolio management, marketing & pricing strategy, as well as price management frameworks and their implementation. He has worked for various chemicals, building and base materials producers in contested market environments as well as more for specialized products.

Omar Ahmad

Omar is a Senior Partner, Member of the Board, and Head of Healthtech at Simon-Kucher.

Christoph Engelke

Christoph is a Partner in Simon-Kucher’s global Healthcare & Life Sciences division and works out of the Munich office.

Xi Bing Ang

Xi Bing Ang is a Partner based in the London office of Simon-Kucher & Partners. He specialises in pricing and growth strategies for B2B software companies as well as B2B data & intelligence providers.

Rory Liu

Francesco Fiorese

Francesco Fiorese is a Partner and co-Managing Director of Italy at Simon-Kucher. He advises market leaders in Italy and internationally in various B2B- and B2C- focused industries on how to achieve TopLine growth and Commercial Excellence. His clients include companies from Technology & Industrials, Distribution and Consumer Goods industries.

Christian Schuler

Christian Schuler is a Senior Partner and the Head of the Health Sector at Simon-Kucher. Based in the company's Munich office in Germany, he has also worked in the San Francisco and Bonn offices. Before assuming his current role, he served as the Global Head of Pharma & Biotech.